Cargando…
Phosphorylation of androgen receptors at serine 515 is a potential prognostic marker for triple negative breast cancer
1.7 million cases of breast cancer are diagnosed every year with 522,000 deaths. Molecular classifications of breast cancer have resulted in improved treatments. However, treatments for triple negative breast cancer (TNBC) are lacking. Analysis of molecular targets for TNBC is a priority. One potent...
Autores principales: | Roseweir, Antonia K., McCall, Pamela, Scott, Alison, Liew, Benjamin, Lim, Zhi, Mallon, Elizabeth A., Edwards, Joanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514900/ https://www.ncbi.nlm.nih.gov/pubmed/28415597 http://dx.doi.org/10.18632/oncotarget.16420 |
Ejemplares similares
-
Androgen receptor phosphorylation at serine 515 by Cdk1 predicts biochemical relapse in prostate cancer patients
por: Willder, J M, et al.
Publicado: (2013) -
Androgen Receptor Phosphorylation at Serine 308 and Serine 791 Predicts Enhanced Survival in Castrate Resistant Prostate Cancer Patients
por: McCall, Pamela, et al.
Publicado: (2013) -
Phosphorylation of the androgen receptor is associated with reduced survival in hormone-refractory prostate cancer patients
por: McCall, P, et al.
Publicado: (2008) -
Androgen receptor phosphorylation status at serine 578 predicts poor outcome in prostate cancer patients
por: Patek, SC, et al.
Publicado: (2016) -
SUN-LB134 Androgen Receptor Phosphorylated at Serine 815 in Mouse and Human Prostates
por: Yokobori, Kosuke, et al.
Publicado: (2020)